Higher carbohydrate antigen 125 levels are associated with increased risk of coronary heart disease in elderly Chinese: A population-based case-control study

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Li, Xiaorong ^a,b   He, Meian ^b   Zhu, Jiang ^c   Yao, Ping ^b   Li, Xiulou ^c   Yuan, Jing ^b   Min, Xinwen ^c   Lang, Mingjian ^c   Yang, Handong ^c   Hu, Frank B ^d   Wu, Tangchun ^b   Wei, Sheng ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CA 125 ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHINA; CHINESE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRINKING; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PENSIONER; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; SMOKING;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CA-125 ANTIGEN; CASE-CONTROL STUDIES; CHINA; COMORBIDITY; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PUBLIC HEALTH SURVEILLANCE; RISK; SEVERITY OF ILLNESS INDEX;

EID: 84896731194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081328     Document Type: Article

References (49)

1. Kenemans P, Yedema CA, Bon GG, von Mensdorff-Pouilly S (1993) CA 125 in gynecological pathology - a review. Eur J Obstet Gynecol Reprod Biol 49: 115-124. doi:10.1016/0028-2243(93)90135-Y. PubMed: 8365505. (Pubitemid 23233193)
2. Sikaris KA (2011) CA125 - a test with a change of heart. Heart Lung Circ 20: 634-640. doi:10.1016/j.hlc.2010.08.001. PubMed: 20822954.
3. Saygili U, Guclu S, Uslu T, Erten O, Dogan E (2002) The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma. Int J Gynecol Cancer 12: 438-442. doi:10.1046/j.1525-1438.2002.01171.x. PubMed: 12366659.
4. Topalak O, Saygili U, Soyturk M, Karaca N, Batur Y et al. (2002) Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol 85: 108-113. doi:10.1006/gyno.2001.6575. PubMed: 11925128. (Pubitemid 34304018)
5. Kouris NT, Zacharos ID, Kontogianni DD, Goranitou GS, Sifaki MD et al. (2005) The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail 7: 199-203. doi:10.1016/j.ejheart.2004.07.015. PubMed: 15701467. (Pubitemid 40215613)
6. D'Aloia A, Faggiano P, Aurigemma G, Bontempi L, Ruggeri G et al. (2003) Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol 41: 1805-1811. doi:10.1016/S0735-1097(03)00311-5. PubMed: 12767668. (Pubitemid 36584256)
7. Varol E, Ozaydin M, Dogan A, Kosar F (2005) Tumour marker levels in patients with chronic heart failure. Eur J Heart Fail 7: 840-843. doi: 10.1016/j.ejheart.2004.12.008. PubMed: 15916923. (Pubitemid 41125903)
8. De Gennaro L, Brunetti ND, Bungaro R, Montrone D, Cuculo A et al. (2009) Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome. Coron Artery Dis 20: 274-280. doi:10.1097/MCA.0b013e3283229d82. PubMed: 19440066.
9. Turk HM, Pekdemir H, Buyukberber S, Sevinc A, Camci C et al. (2003) Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol 24: 172-175. doi: 10.1159/000074425. PubMed: 14654710. (Pubitemid 37500565)
10. Varol E, Ozaydin M, Altinbas A, Aslan SM, Dogan A et al. (2007) Elevated carbohydrate antigen 125 levels in hypertrophic cardiomyopathy patients with heart failure. Heart Vessels 22: 30-33. doi:10.1007/s00380-006-0938-9. PubMed: 17285443. (Pubitemid 46477187)
11. Ragni T, Da Col U, Di Manici G, Di Bella I, Di Lazzaro D et al. (2003) A case of pseudoaneurysm of the left ventricular lateral wall. Diagnosis and surgical treatment. Ital Heart J Suppl 4: 340-343. PubMed: 12784770.
12. Yanada M, Shimada J, Ito K, Terauchi K, Shimomura M (2007) Cardiac angiosarcoma with diagnostic difficulty. Kyobu Geka 60: 1148-1151. PubMed: 18078079.
13. Chelbi F, Hamzaoui A, Kacem M, Hammami S, Mahjoub S (2002) Increase of CA-125 in pericardial tamponade. Presse Med 31: 1366. PubMed: 12375390.
14. Rostoff P, Mroczek-Czernecka D, Piwowarska W (2008) Elevated CA-125 level in acute heart failure due to Toxoplasma gondii perimyocarditis. Int J Cardiol 130: e114-e116. doi:10.1016/j.ijcard.2007.07.018. PubMed: 17689762.
15. De Gennaro L, Brunetti ND, Montrone D, De Rosa F, Cuculo A et al. (2012) Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation. Eur J Clin Invest 42: 371-375. doi: 10.1111/j.1365-2362. 2011.02592.x. PubMed: 21913917.
16. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S et al. (2010) Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121: e46-e215. doi:10.1161/CIRCULATIONAHA.109.192667. PubMed: 20019324.
17. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD et al. (2011) Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123: e18-e209. doi:10.1161/CIR.0b013e3182009701. PubMed: 21160056.
18. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD et al. (2012) Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125: e2-e220. doi:10.1161/CIR.0b013e31823ac046. PubMed: 22179539.
19. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442. doi:10.1371/journal.pmed.0030442. PubMed: 17132052.
20. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126. doi:10.1056/NEJM199901143400207. PubMed: 9887164.
21. Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22: 361-403. doi: 10.1146/annurev.immunol.22. 012703.104644. PubMed: 15032582. (Pubitemid 38680427)
22. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874. doi:10.1038/nature01323. PubMed: 12490960.
23. van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES et al. (2008) Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) 47: 3-7. doi:10.1093/rheumatology/kem202. PubMed: 17702769. (Pubitemid 350286254)
24. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM et al. (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112: 3337-3347. doi:10.1161/CIRCULATIONAHA.104.507996. PubMed: 16301360. (Pubitemid 43739380)
25. Righi L, Volante M, Rapa I, Tavaglione V, Inzani F et al. (2010) Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. Endocr Relat Cancer 17: 977-987. doi:10.1677/ERC-10-0157. PubMed: 20817788.
26. Epiney M, Bertossa C, Weil A, Campana A, Bischof P (2000) CA125 production by the peritoneum: in-vitro and in-vivo studies. Hum Reprod 15: 1261-1265. doi:10.1093/humrep/15.6.1261. PubMed: 10831552. (Pubitemid 30335947)
27. Kosar F, Aksoy Y, Ozguntekin G, Ozerol I, Varol E (2006) Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail 8: 270-274. doi:10.1016/j.ejheart.2005.09.002. PubMed: 16309955. (Pubitemid 44275312)
28. Wang F, Zhu J, Yao P, Li X, He M et al. (2013) Cohort profile: The Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol, 42: 731-40. PubMed: 22531126.
29. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC et al. (2012) 2012ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and managementof patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association forThoracic Surgery, Preventive Cardiovascular Nurses Association, Society forCardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol18;60Volumes 24: e44-e164
30. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33 Suppl 1: S62-S69. doi:10.2337/dc10-S062. PubMed: 20042775.
31. Vizzardi E, Nodari S, D'Aloia A, Chiari E, Faggiano P et al. (2008) CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure. Echocardiography 25: 955-960. doi:10.1111/j.1540-8175.2008.00714.x. PubMed: 18771557.
32. Antonini-Canterin F, Popescu BA, Popescu AC, Beladan CC, Korcova R et al. (2008) Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement. Int J Cardiol 128: 406-412. doi: 10.1016/j.ijcard.2007.05.039. PubMed: 17662495.
33. Duman C, Ercan E, Tengiz I, Bozdemir H, Ercan HE et al. (2003) Elevated serum CA 125 levels in mitral stenotic patients with heart failure. Cardiology 100: 7-10. doi:10.1159/000072385. PubMed: 12975539. (Pubitemid 37140412)
34. Yalta K, Yilmaz A, Turgut OO, Erselcan T, Yilmaz MB et al. (2006) Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction. Adv Ther 23: 1052-1059. doi:10.1007/BF02850225. PubMed: 17276972. (Pubitemid 46341062)
35. Sugishita H, Imagawa H, Kawachi K, Takano S, Tsunooka N et al. (2005) Normalization of cancer antigen 125 after mitral valve replacement in a patient with congestive heart failure due to mitral valve endocarditis. Jpn J Thorac Cardiovasc Surg 53: 486-489. doi: 10.1007/s11748-005-0092-9. PubMed: 16200889. (Pubitemid 41441890)
36. Varol E, Yücel H, Arslan A, Ozaydin M, Erdoǧan D et al. (2012) Elevated carbohydrate antigen 125 levels in patients with aortic stenosis: relation to clinical severity and echocardiographic parameters. Turk Kardiyol Dern Ars 40: 309-315. doi:10.5543/tkda.2012.87894. PubMed: 22951846.
37. Ozeren A, Aydin M, Tokac M, Demircan N, Unalacak M et al. (2003) Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris. Mediators Inflamm 12: 361-365. doi:10.1080/ 09629350310001633360. PubMed: 14668096. (Pubitemid 38161144)
38. Huang F, Chen J, Liu Y, Zhang K, Wang J et al. (2012) New mechanism of elevated CA125 in heart failure: The mechanical stress and inflammatory stimuli initiate CA125 synthesis. Med Hypotheses 26: 26. PubMed: 22743023.
39. Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z et al. (1998) CA 125: the past and the future. Int J Biol Markers 13: 179-187. PubMed: 10228898. (Pubitemid 29178546)
40. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC et al. (1983) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 2: 275-285. doi:10.1097/ 00004347-198303000-00005. PubMed: 6196309. (Pubitemid 14176989)
41. Turgut O, Tandogan I, Yilmaz MB, Gul I, Zorlu A (2011) CA125 in heart failure: implications for immunoinflammatory activity. Int J Cardiol 146: 99-100. doi:10.1016/j.ijcard.2010.05.077. PubMed: 20580098.
42. Leard LE, Broaddus VC (2002) Mesothelial cells: their structure, function and role in serosal repair. Respirology 7: 171-191. doi: 10.1046/j.1440-1843. 2002.00404.x. PubMed: 12153683.
43. Leard LE, Broaddus VC (2004) Mesothelial cell proliferation and apoptosis. Respirology 9: 292-299. doi:10.1111/j.1440-1843.2004.00602.x. PubMed: 15362999. (Pubitemid 39382110)
44. Zeillemaker AM, Verbrugh HA, Hoynck van Papendrecht AA, Leguit P (1994) CA 125 secretion by peritoneal mesothelial cells. J Clin Pathol 47: 263-265. doi:10.1136/jcp.47.3.263. PubMed: 8163699. (Pubitemid 24120692)
45. Johnson CC, Kessel B, Riley TL, Ragard LR, Williams CR et al. (2008) The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. Gynecol Oncol 110: 383-389. doi:10.1016/j.ygyno.2008.05.006. PubMed: 18586313.
46. El-Mesallamy HO, Hamdy NM, Salman TM, Ibrahim SM (2012) Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease. Angiology 63: 96-102. doi:10.1177/ 0003319711408587. PubMed: 21602254.
47. Csordas A, Wick G, Laufer G, Bernhard D (2008) An Evaluation of the Clinical Evidence on the Role of Inflammation and Oxidative Stress in Smoking-Mediated Cardiovascular Disease. Biomark Insights 3: 127-139. PubMed: 19578488. (Pubitemid 351419504)
48. Wright WR, Parzych K, Crawford D, Mein C, Mitchell JA et al. (2012) Inflammatory transcriptome profiling of human monocytes exposed acutely to cigarette smoke. PLOS ONE 7: e30120. doi:10.1371/journal.pone.0030120. PubMed: 22363418.
49. Joo NS, Kim KN, Kim KS (2011) Serum CA125 concentration has inverse correlation with metabolic syndrome. J Korean Med Sci26(10): 1328-1332. doi:10.3346/jkms.2011.26.10.1328. PubMed: 22022186.